Publicaciones en las que colabora con JOSE MANUEL PORCEL PEREZ (20)

2022

  1. A Simple Scoring System to Differentiate Bacterial from Viral Infections in Acute Exacerbations of COPD Requiring Hospitalization

    International Journal of COPD, Vol. 17, pp. 773-779

  2. Taponamiento cardiaco como forma de presentación inicial de un linfoma linfoblástico de células T

    Galicia Clínica, Vol. 83, Núm. 2, pp. 42-44

2016

  1. The Diagnostic Value of Serum C-Reactive Protein for Identifying Pneumonia in Hospitalized Patients with Acute Respiratory Symptoms

    Journal of Biomarkers, Vol. 2016

2014

  1. A pilot study on the diagnostic accuracy of proadrenomedullin and proatrial natriuretic peptide in lower respiratory tract infections

    Open Respiratory Medicine Journal, Vol. 8, Núm. 1, pp. 22-27

  2. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions

    Lung, Vol. 192, Núm. 4, pp. 577-581

2012

  1. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions

    European Journal of Internal Medicine, Vol. 23, Núm. 5, pp. 447-450

2011

  1. Predictive factors, microbiology and outcome of patients with parapneumonic effusion

    European Respiratory Journal, Vol. 38, Núm. 5, pp. 1173-1179

  2. Triggering receptor (TREM-1) expressed on myeloid cells predicts bacteremia better than clinical variables in community-acquired pneumonia

    Respirology, Vol. 16, Núm. 2, pp. 321-325

2010

  1. C-reactive protein for discriminating treatment failure from slow responding pneumonia

    European Journal of Internal Medicine, Vol. 21, Núm. 6, pp. 548-552

  2. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia

    Thorax, Vol. 65, Núm. 2, pp. 101-106

2009

  1. A prediction rule for estimating the risk of bacteremia in patients with community-acquired Pneumonia

    Clinical Infectious Diseases, Vol. 49, Núm. 3, pp. 409-416

  2. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli

    Respirology, Vol. 14, Núm. 1, pp. 105-111

2008

  1. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease

    Respirology, Vol. 13, Núm. 7, pp. 1028-1033

  2. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions

    Respirology, Vol. 13, Núm. 1, pp. 58-62

2007

  1. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria

    Respirology, Vol. 12, Núm. 5, pp. 654-659

  2. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia

    Chest, Vol. 131, Núm. 5, pp. 1442-1447

  3. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease

    Respirology, Vol. 12, Núm. 1, pp. 117-121

2003

  1. Chronic cough and fever at the onset of giant cell arteritis [1]

    Archivos de Bronconeumologia

2000

  1. Community-acquired pneumonia: Development of a bedside predictive model and scoring system to identify the aetiology

    Respiratory Medicine, Vol. 94, Núm. 5, pp. 505-510

1997

  1. Rapid detection of pneumococcal antigen in lung aspirates: Comparison with culture and PCR technique

    Respiratory Medicine, Vol. 91, Núm. 4, pp. 201-206